Virtue Capital Management, LLC Gilead Sciences, Inc. Transaction History

Virtue Capital Management, LLC

$562 Million
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$73.27 - $83.09 $195,411 - $221,601	-2,667 Reduced 33.22%	5,362 $434,000
Q2 2023 Jul 18, 2023	BUY	$76.01 - $86.7 $111,734 - $127,449	1,470 Added 22.41%	8,029 $618,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $113,027 - $128,772	-1,462 Reduced 18.23%	6,559 $544,000
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $499,868 - $717,638	8,021 New	8,021 $688,000
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $149,033 - $167,855	-2,582 Reduced 36.29%	4,533 $280,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $205,847 - $257,949	-3,554 Reduced 33.31%	7,115 $423,000
Q4 2021 Jan 24, 2022	BUY	$64.88 - $73.64 $106,597 - $120,990	1,643 Added 18.2%	10,669 $775,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $48,330 - $52,143	-714 Reduced 7.33%	9,026 $630,000
Q2 2021 Jul 15, 2021	SELL	$63.47 - $69.35 $144,076 - $157,424	-2,270 Reduced 18.9%	9,740 $671,000
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $31,200 - $35,599	520 Added 4.53%	12,010 $776,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $129,728 - $147,819	-2,290 Reduced 16.62%	11,490 $669,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $188,659 - $237,207	-3,038 Reduced 18.06%	13,780 $871,000
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $1.22 Million - $1.41 Million	16,818 New	16,818 $1.29 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $558,722 - $715,642	-8,921 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $269,957 - $296,944	-4,381 Reduced 32.93%	8,921 $580,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $117,393 - $129,582	-1,878 Reduced 12.37%	13,302 $843,000
Q2 2019 Nov 12, 2019	BUY	$61.87 - $69.38 $939,186 - $1.05 Million	15,180 New	15,180 $1.03 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $1.82 Million - $2.38 Million	-30,086 Closed	0 $0
Q3 2018 Feb 13, 2019	BUY	$71.28 - $78.92 $1.07 Million - $1.18 Million	14,982 Added 99.19%	30,086 $2.32 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $146,304 - $170,658	2,255 Added 17.55%	15,104 $1.07 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $73,714 - $89,865	1,012 Added 8.55%	12,849 $951,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $842,202 - $988,626	11,837	11,837 $848,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.

Account